Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study;Efectos de la antibioterapia y la técnica fisioterápica respiratoria en pacientes con fibrosis quística tratados por exacerbación pulmonar aguda: estudio experimental

Archivos de Bronconeumologia

Volumn 46, Issue 6, 2010, Pages 310-316

  da Silva Santos, Camila Isabel ^a   Gonçalves de Oliveira Ribeiro, Maria Angela ^a   Moreno Morcillo, André ^a   Fernando Ribeiro, AntÔnio ^a   Dirceu Ribeiro, José ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Chest physiotherapy; Cystic fibrosis; Paediatric; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; CEFTAZIDIME; OXACILLIN; BRONCHODILATING AGENT; DORNASE ALFA; OXYTETRACYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ANTIBIOTIC THERAPY; ARTICLE; BREATHING EXERCISE; BREATHING RATE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; OXYGEN SATURATION; PHYSIOTHERAPY; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCORING SYSTEM; STAPHYLOCOCCUS INFECTION; TREATMENT RESPONSE; ACUTE DISEASE; ANTHROPOMETRY; DRUG EFFECT; EXPERIMENTAL STUDY; FEMALE; FORCED EXPIRATORY FLOW; HEART RATE; HOSPITAL ADMISSION; INFECTION; LUNG FUNCTION; MALE; NUTRITIONAL VALUE; ARTIFICIAL VENTILATION; CHRONIC DISEASE; COMPLICATION; LUNG DISEASES; MULTIMODALITY CANCER THERAPY; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG DISEASES; MALE; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY THERAPY; YOUNG ADULT;

EID: 77952957686     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(10)70073-2     Document Type: Article

References (30)

1. Prasad S.A., Main E., Dodd M.E. Finding consensus on the physiotherapy management of assymptomatic infants with Cystic Fibrosis. Pediatr Pulmonol 2008, 43:236-244.
2. Döring G., Cönway S.P., Heiherman H.G.M., Hodson M.E., Noiby N., Smyth A., et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000, 16:749-767.
3. Alvarez A.E., Ribeiro A.F., Hessel G., Bertuzzo C.S., Ribeiro J.D. Cystic fibrosis at a Brazilian center of excellence: clinical and laboratory characteristics of 104 patients and their association with genotype and disease severity. J Pediatr 2004, 80:371-379.
4. Smyth A., Elborn J.S. Exacerbations in cystic fibrosis: management. Thorax 2008, 63:180-184.
5. Downey D.G., Brockbank S., Marptin S.L., Ennis M., Elborn J.S. The effect of treatment of cystic fibrosis pulmonary exacerbations on airway and systemic inflamation. Pediatr Pulmonol 2007, 42:729-735.
6. Béghin L., Gottrand F., Michaud L., Loueville G.A., Wizla-Derambure N., Sardet A., et al. Impact of intravenous antibiotic therapy on total daily energy expenditure and physical activity in cystic fibrosis children with Pseudomonas aeruginosa pulmonary exacerbation. Pediatr Res 2003, 54:756-761.
7. Bradley J., Mc.Alister O., Elborn S. Pulmonar function, inflammation, exercise capacity and quality of life in cystic fibrosis. Eur Respir J 2001, 17:712-715.
8. Vendrell M., Gracia J., Olveira C., Martínez M.A., Girón R., Máiz L., et al. Diagnosis and treatment of bronchiectasis. Arch Bronconeumol 2008, 44:629-640.
9. Mcllwaine M. Chest physical therapy, breathing techniques and exercise in children with cystic fibrosis. Paediatr Respir Rev 2007, 8:8-16.
10. Bradley J.M., Moran F.M., Elborn J.S. Evidence for physical therapies (airway clearance and physical training) in cystic fibrosis: An overview of five Cochrane systematic reviews. Respir Med 2006, 100:191-201.
11. Clinical Guidelines for the Physiotherapy Management of Cystic Fibrosis. Cftrust.org [homepage on the Internet]. UK: Association of Chartered Physiotherapist in Cystic Fibrosis. (ACPCF); [updated 2002 January 16; cited 2002 Jul 9]. Avaliable from: http://www.cftrust.org.uk.
12. Hess D.R. The evidence for secretion clearance techniques. Respir Care 2001, 46:1276-1292.
13. Hafen G.M., Ranganathan S.C., Roberptson C.F., Robinson P.J. Clinical Scoring System in Cystic Fibrosis. Pediatr Pulmonol 2006, 41:602-617.
14. Santos C.I.S., Ribeiro J.D., Ribeiro A.F., Hessel G. Critical analise for cystic fibrosis clinical scores: state of art. J Bras Pneumol 2004, 30:286-298.
15. Newton T.J. Respiratory care of the hospitalized patient with cystic fibrosis. Respir Care 2009, 54:769-775. discussion 775-6.
16. Kanga J., Kuhn R., Craigmyle L., Haverstock D., Church D. Cystic Fibrosis Clinical Score: a new scoring system to evaluate acute pulmonary exacerbation. Clin Ther 1999, 21:1343-1356.
17. Ramsey B.W., Boat T.F. Outcome measures for clinical trials in Cystic Fibrosis. Summary of a Cystic fibrosis Foundation Consensus Conference. J Pediatr 1994, 124:177-192.
18. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995, 152:1107-1136. American Thoracic Society.
19. Homnick D. Making airway clearance successful. Paediatric Respir Rev 2007, 8:40-45.
20. Williams M.T., Parson D.W., Frick R.A., Ellis E.R., Martin A.J., Giles S.E., et al. Acute respiratory infection in patients with cystic fibrosis with mild pulmonary impairment: comparison of two physiotherapy regimens. Aust J Physiother 2001, 47:227-236.
21. Ren C.L., Brucker J.L., Rovitelli A.K., Bordeaux K.A. Changes in lung function measured by spirometry and the forced oscillation technique in cystic fibrosis patients undergoing treatment for respiratory tract exacerbation. Pediatr Pulmonol 2006, 41:345-349.
22. Braggion C., Cappelletti L.M., Cornacchia M., Zanolla L., Mastella G. Short-term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbation of cystic fibrosis: a cross-over randomized study. Pediatr Pulmonol 1995, 19:16-22.
23. Brosworpth D.G., Nielson D.W. Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis. Pediatr Pulmonol 1997, 24:42-47.
24. Oberwaldner B., Theissi B., Rucker A., Zach M.S. Chest physiotherapy in hospitalized patients with cystic fibrosis: a study of lung function effects and sputum production. Eur Respir J 1991, 4:152-158.
25. Hess D.R. Airway clearance: physiology, pharmacology, techniques and practice. Respir Care 2007, 52:1392-1396.
26. Rodrigues J.R., Pereira C.A.C. Spirometric response to bronchodilators: which parameters and values are clinically relevant in obstructive diseases?. J Pneumol 2001, 27:35-47.
27. Dorlochter L., Ola R., Helgheim V., Rosendahl K., Fluge G. Resting energy expenditure and lung disease in cystic fibrosis. J Cyst Fibros 2002, 1:131-136.
28. Castro M., Diamanti A., Gambarra M., Bella S., Lucidi V., Papadatou B., et al. Resting energy expenditure in young patients with cystic fibrosis receiving antibiotic therapy for acute respiratory exacerbations. Clin Nutr 2002, 21:141-144.
29. Van der Shans C.P. Bronchial mucus transport. Respir Care 2007, 52:1150-1156.
30. Zach M.S. The physiology of forced expiration. Paediatr Respir Rev 2000, 1:3-39.